Hematocrit on TRT: When to Worry and What to Do

Testosterone stimulates erythropoietin (EPO) production in the kidneys, which signals bone marrow to manufacture more red blood cells. It also reduces hepcidin, freeing up more iron for erythropoiesis. The net effect: red blood cell volume goes up, plasma volume stays roughly constant, hematocrit rises.

This happens to virtually everyone on TRT. The question is how much. Studies put the prevalence of erythrocytosis (HCT > 52%) on injectable TRT at 25–40% within the first year. Topical T has a much lower rate (~5%); the slower, smoother absorption from gels and creams produces less EPO spike.

Normal: 41–50% for adult men.

Watch zone (50–52%): monitor every 3 months, check trend, ensure good hydration before draws.

Intervention zone (52–54%): start the four-step fix below. Don't wait.

Risk zone (>54%): meaningful elevation in thromboembolic risk — stroke, heart attack, deep vein thrombosis, pulmonary embolism. Most TRT guidelines mandate intervention here.

Note: a single high reading is not a verdict. Dehydration can artifactually raise HCT by 1–3 points. If you got an HCT of 53% after a hard workout and a sleepless night, hydrate and retest before changing anything.

Blood with a hematocrit of 55% is genuinely thicker than blood at 45% — viscosity increases roughly exponentially with HCT in the upper range. Higher viscosity means:

• Slower microcirculation • Higher cardiac workload • Greater risk of clot formation in low-flow vessels (calf veins, atrial appendage) • Worse exercise tolerance — counterintuitively, you fatigue faster despite higher oxygen-carrying capacity

The epidemiology is mixed on hard cardiovascular endpoints in HCT 52–55% TRT patients, but the trend is clear at higher numbers. There's no upside to letting HCT drift up indefinitely.

Step 1: Verify and hydrate. If your HCT is borderline, drink 500 mL of water in the 30 minutes before your next draw. Avoid intense exercise the day before. Re-draw. Some 'high' HCTs evaporate.

Step 2: Split your dose. This is the single most effective change for most men. Going from once-weekly to twice-weekly (or every 3.5 days) cuts the peak testosterone level, which cuts the EPO spike, which slows red cell production. Men routinely drop 2–4 HCT points by doing nothing other than splitting their weekly dose into two injections.

Daily subcutaneous micro-dosing flattens the curve even more — for men who can tolerate the injection schedule, this is the gentlest option for HCT.

Step 3: Lower the total weekly dose. If splitting alone isn't enough, drop the total weekly testosterone by 20–25 mg. This often costs you 50–100 ng/dL of total T but saves the HCT problem. Most men feel the same at the lower dose as long as free T stays decent.

Step 4: Therapeutic phlebotomy. Donating blood every 8–12 weeks. Each whole-blood donation removes ~500 mL of blood (roughly 200–230 mL of red cells) and drops HCT by 3–5 points. Free Red Cross donations qualify if you're eligible (most TRT users are). Otherwise, get a phlebotomy script from your TRT clinic and use a hospital outpatient lab.

Double-red apheresis donations drop HCT more (~6–8 points) but require a longer recovery interval (16 weeks).

Aggressive phlebotomy in someone with marginal iron stores can crash ferritin to single digits, causing fatigue that mimics low testosterone. Before becoming a frequent donor, check ferritin. If you're below 50 ng/mL, address iron first (a small daily supplement, or dietary red meat / liver) before donating again.

Conversely, some men with high HCT also have hemochromatosis — genetically high iron absorption. For them, phlebotomy is therapeutic for both. Check ferritin and transferrin saturation if your HCT keeps climbing despite dose adjustments — TSAT > 45% with high ferritin warrants HFE genetic testing.

Some TRT clinicians prescribe low-dose aspirin (81 mg daily) for men with persistently high HCT as antiplatelet prophylaxis. The evidence base is thin — aspirin reduces platelet aggregation, but the dominant clot risk in TRT-induced polycythemia is from erythrocyte-related viscosity, not platelets per se. Use under physician guidance, weigh GI bleed risk against unclear CV benefit.

Nattokinase, vitamin E, and various supplements are sometimes promoted as 'natural blood thinners' for high HCT. Evidence is weak. Focus on the four-step protocol above.

If you've split your dose, lowered it, addressed iron, and are donating every 8 weeks, and HCT still climbs above 54%, you're in territory that warrants:

• Sleep apnea workup. Untreated OSA is the most common confounder — nocturnal hypoxia drives EPO independently of TRT. Many TRT men feel dramatically better, AND drop HCT 4–6 points, after starting CPAP.

• Smoking cessation. Same chronic hypoxia mechanism.

• Move to a topical formulation. Cream or gel testosterone produces much less HCT rise than injections. The tradeoff is higher DHT and inconsistent absorption.

• Pause TRT. The nuclear option. Reserved for true risk patients — recent thromboembolism, family history of polycythemia vera, etc.

At this point, you should be working with a knowledgeable urologist or hematologist, not just a TRT clinic.

Hematocrit rising on TRT is normal. Hematocrit above 54% is a problem. The fix is rarely complicated: split your dose, lose visceral fat, donate blood, and rule out sleep apnea. Most men can stay on TRT indefinitely with HCT comfortably in the high 40s if they take this seriously from month three onward.